Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Bros. Advisors (gp) Llc
Relationship:  
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   16    
Direct Shares   608,718    

Indirect Shares

   158,658,441      
Direct Value   $42,508,355    

Indirect Value

   $12,755,792,609      
Total Shares   159,267,159      
Total Value   $12,798,300,963      


Incyte Corp $31,839,496 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327 Incyte Corp $31,839,496 Synageva BioPharma Corp $0 Mirati Therapeutics, Inc. $16,084 Seagen Inc $10,649,448 Neurogene $3,327
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    1    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -74.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Genomic Health Inc GHDX Director, 10% Owner 2013-07-01 0 2019-02-27 9,235,362    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2014-03-05 0 2016-04-01 41,897,946    Premium*  
            Incyte Corp INCY Director, 10% Owner 2021-05-14 559,963 2021-05-14 29,367,926    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2014-05-22 0 2014-05-22 518,849    Premium*  
            Aceragen, Inc ACGN Director 2014-07-01 0 2016-01-04 78,885    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-01-07 1,020 2015-01-07 11,877,394    Premium*  
            Mirati Therapeutics, Inc. MRTX 10% Owner 2016-06-09 274 2016-06-09 30,003    Premium*  
            Intellia Therapeutics, Inc. NTLA Former 10% owner 2016-05-11 0 2016-05-11 976,214    Premium*  
            Invitae Corp NVTA 10% Owner 2016-11-17 0 2016-11-17 6,554,039    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 2017-03-24 0 2023-11-22 2,168,818    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2023-05-31 46,557 2023-05-31 42,977,301    Premium*  
            Neurogene NGNE Director, 10% Owner 2023-10-05 904 2023-10-05 1,658,190    Premium*  
            Entrada Therapeutics, Inc. TRDA 10% Owner 2022-05-16 0 2022-06-06 4,501,658    Premium*  
            Atreca Inc BCEL Former 10% Owner 2023-10-19 0 2023-10-19 2,971,128    Premium*  
            Igm Biosciences, Inc. IGMS 2023-12-13 0 2024-03-29 3,755,474    Premium*  
            Vtv Therapeutics Inc. VTVT 2024-03-05 0 2024-03-05 89,254    Premium*  
* Premium Members only  

Records found :    103         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BLCM Bellicum Pharmaceuticals,... 10% Owner   –       –       •   2023-05-05 3 IO $0.00 $0 I/I 0 249,123 %
VTVT Vtv Therapeutics Inc.   –       •      –    2024-02-27 3 IO $0.00 $0 I/I 0 154,971 -
MRTX Mirati Therapeutics, Inc. 10% Owner   –       –       •   2016-03-30 4 OE $6.74 $1,847 D/D 274 137 0 -
INCY Incyte Corp Director   –       •       •   2015-10-01 4 A $110.33 $56,930 I/I 516 512,845 0 -
INCY Incyte Corp Director   –       •       •   2015-12-31 4 A $108.45 $56,936 I/I 525 513,020 0 -
INCY Incyte Corp Director   –       •       •   2015-07-01 4 A $104.21 $56,899 I/I 546 411,021 0 -
INCY Incyte Corp Director   –       •       •   2016-09-30 4 A $94.29 $56,857 I/I 603 533,720 0 -
INCY Incyte Corp Director   –       •       •   2016-06-30 4 A $79.98 $56,866 I/I 711 533,519 0 -
INCY Incyte Corp Director   –       •       •   2016-03-31 4 A $72.47 $56,961 I/I 786 533,282 0 -
IGMS Igm Biosciences, Inc.   –       •       •   2023-12-29 4 A $0.00 $0 I/I 1,108 3,390,877 0 -
TRDA Entrada Therapeutics, Inc... 10% Owner   –       –       •   2022-06-02 4 B $5.82 $15,383 I/I 2,643 4,467,393 1.5 -
SGEN Seagen Inc Director   –       •       •   2022-05-13 4 A $0.00 $0 I/I 3,006 42,966,507 0 -
GHDX Genomic Health Inc Director   –       •       •   2013-07-01 4 A $32.85 $119,443 I/I 3,636 301,821 0 -
GHDX Genomic Health Inc Director   –       •       •   2015-01-01 4 A $31.97 $119,696 I/I 3,744 305,953 0 -
GHDX Genomic Health Inc Director   –       •       •   2018-04-01 4 A $31.29 $119,778 I/I 3,828 339,585 0 -
GHDX Genomic Health Inc Director   –       •       •   2015-04-01 4 A $30.43 $119,772 I/I 3,936 306,609 0 -
GHDX Genomic Health Inc Director   –       •       •   2013-10-01 4 A $30.33 $119,743 I/I 3,948 302,479 0 -
IGMS Igm Biosciences, Inc.   –       •       •   2024-03-29 4 A $0.00 $0 I/I 3,988 3,755,474 0 -
SGEN Seagen Inc Director   –       •       •   2023-05-31 4 A $0.00 $0 I/I 4,088 42,977,301 0 -
GHDX Genomic Health Inc Director   –       •       •   2014-01-01 4 A $29.27 $119,773 I/I 4,092 303,161 0 -
GHDX Genomic Health Inc Director   –       •       •   2014-10-01 4 A $28.54 $119,868 I/I 4,200 305,329 0 -
GHDX Genomic Health Inc Director   –       •       •   2014-07-01 4 A $27.86 $119,687 I/I 4,296 304,629 0 -
GHDX Genomic Health Inc Director   –       •       •   2015-07-01 4 A $27.34 $119,749 I/I 4,380 307,339 0 -
GHDX Genomic Health Inc Director   –       •       •   2014-04-01 4 A $26.57 $119,884 I/I 4,512 303,913 0 -
INCY Incyte Corp Director   –       •       •   2016-02-25 4 B $74.00 $495,800 I/I 6,700 19,015,852 2.25 -
  103  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us